Arcturus Therapeutics Price Target Cut to $20.00/Share From $23.00 by BTIG
Ratings actions from Benzinga: GMT) Arcturus Therapeutics Is Maintained at Buy by BTIGRatings actions from Benzinga
Ratings actions from Benzinga: GMT) Arcturus Therapeutics Is Maintained at Buy by BTIGRatings actions from Benzinga